Pre-ischemic treatment with memantine reversed the neurochemical and behavioural parameters but not energy metabolites in middle cerebral artery occluded rats

Pharmacology Biochemistry and Behavior

Volumn 92, Issue 3, 2009, Pages 424-432

  Babu, C Saravana ^a   Ramanathan, M ^b  

^a SRI RAMACHANDRA UNIVERSITY   (India)

^b PSG COLLEGE OF PHARMACY   (India)

Author keywords

Cerebral ischemia; Glutamate; Memantine; Middle cerebral artery occlusion (MCAO); Neuron glia interactions; NMDA receptors; Therapeutic time window

Indexed keywords

ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); ADENOSINE TRIPHOSPHATE; GLUTAMATE AMMONIA LIGASE; GLUTAMIC ACID; GLUTATHIONE; LACTIC ACID; MEMANTINE; NICOTINAMIDE ADENINE DINUCLEOTIDE; PYRUVIC ACID;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN ISCHEMIA; BRAIN REGION; CONTROLLED STUDY; DRUG EFFECT; ENZYME ACTIVITY; HISTOPATHOLOGY; MALE; MIDDLE CEREBRAL ARTERY OCCLUSION; NERVE DEGENERATION; NEUROCHEMISTRY; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; RAT; STROKE;

ADENOSINE TRIPHOSPHATE; ANIMALS; BEHAVIOR, ANIMAL; BRAIN; GLUTAMATE-AMMONIA LIGASE; GLUTAMINE; GLUTATHIONE; LACTIC ACID; MALE; MEMANTINE; MIDDLE CEREBRAL ARTERY; PYRUVIC ACID; RATS; RATS, SPRAGUE-DAWLEY; SODIUM-POTASSIUM-EXCHANGING ATPASE;

RATTUS;

EID: 62549090539     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pbb.2009.01.010     Document Type: Article

References (37)

1. Arundine M., and Tymianski M. Molecular mechanisms of glutamate dependent neuro-degeneration in ischemia and traumatic brain injury. Cell Mol Life Sci 61 (2004) 657-668
2. Babu S.C., Sunil A.G., Vasanthi H.R., Ramanathan M., and Muthusamy V.S. Development and validation of an HPTLC method for simultaneous estimation of excitatory neurotransmitters in rat brain. J Liq Chromatogr Relat Technol 30 (2007) 1-12
3. Bederson J.B., Pitts L.H., Tsuhi M., Nishimura M.C., Davis R.L., and Bartkowski H. Rat middle cerebral artery occlusion: evaluation of the model and development of a neurologic examination. Stroke 17 (1986) 472-476
4. Benarroch E.E. Neuron-astrocyte interactions: partnership for normal function and disease in the central nervous system. Mayo Clin Proc 80 (2005) 1326-1338
5. Block F., and Schwarz M. Dextromethorphan reduces functional deficits and neuronal damage after global ischemia in rats. Brain Res 741 (1996) 153-159
6. Block F., and Schwarz M. Memantine reduces functional and morphological consequences induced by global ischemia in rats. Neurosci Lett 208 (1996) 41-44
7. Cooper A.J.L., Mora S.N., Cruz N.E., and Gelbard A.S. Cerebral ammonia metabolism in hyperammonemic rats. J Neurochem 44 (1985) 1716-1723
8. Culmsee C., Junker V., Kremers W., Thal S., Plesnila N., and Krieglstein J. Combination therapy in ischemic stroke: synergistic neuroprotective effects of memantine and clenbuterol. Stroke 35 (2004) 1197-1202
9. Czok, R., Lamprecht, W. Pyruvate, phosphenolpyruvate and d-glycerate-2-phosphate: Begmeyer, H.U. editor. Methods of Enzymatic Analysis. New York: Verlag Chemie, Weinheim; Academic Press; 1974. p.1446-1451.
10. Dawson L.A., Djali C.S., Gonzales M.A., Vinegra, and Zaleska M.M. Characterization of transient focal ischemia-induced increases in extracellular glutamate and aspartate in spontaneously hypertensive rats. Brain Res Bull 53 (2000) 767-776
11. Dringen R. Metabolism and functions of glutathione in brain. Prog Neurobiol 62 (2000) 649-671
12. Endres M., Wang Z.Q., Namura S., Waeber C., and Moskowitz M.A. Ischemic brain injury is mediated by the activation of poly (ADP-ribose)polymerase. J Cereb Blood Flow Metab 17 (1997) 1143-1151
13. Hata R., Maeda K., Hermann D., Mies G., and Hossmann K.A. Evolution of brain infarction after transient focal cerebral ischemia in mice. J Cereb Blood Flow Metab 20 (2000) 937-946
14. Ikonomidou C., and Turski L. Why did NMDA receptor antagonists fail clinical trials for stroke and traumatic brain injury?. Lancet Neurol 1 (2002) 383-386
15. Johnson J.W., and Kotermanski S.E. Mechanism of action of memantine. Current Opin Pharmacol 6 (2006) 61-67
16. Jollow D.J., Mitchell J.R., Zampaglione N., and Gillete J.R. Bromobenzene induced liver necrosis: protective role of glutathione and evidence for 3,4-bromobenzene as the hepatotoxic metabolite. Pharmacology 11 (1974) 151-169
17. Kornhuber J., and Weller M. Psychotogenecity and N-methyl-d-aspartate receptor antagonism: implications for neuroprotective pharmacotherapy. Biol Psychiatry 41 (1997) 135-144
18. Labiche L.A., and Grotta J.C. Clinical trials for cytoprotection in stroke. Neuro Therapeutics 1 (2004) 46-70
19. Lipton S.A. Failures and successes of NMDA receptor antagonists: molecular basis for the use of open-channel blockers like memantine in the treatment of acute and chronic neurologic insults. NeuroRx 1 (2004) 101-110
20. Lipton S.A. Paradigm shift in neuroprotection by NMDA receptor blockade: memantine and beyond. Nat Rev Drug Discov 5 (2006) 1-11
21. Lister J. Ethologically based animal models of anxiety disorders. Pharmacol Ther 46 (1990) 321-340
22. Longa E.Z., Weinstein P.R., Carlson S., and Cummins R. Reversible middle cerebral artery occlusion without craniectomy in rats. Stroke 20 (1989) 84-91
23. Lowry O.H., Rosenborough N.J., Farr A.L., and Randal R.J. Protein measurement with Folin phenol reagent. J Biol Chem 193 (1951) 265-275
24. Macleod M.R., O'Collins T., Howells D.W., and Donnan G.A. Pooling of animal experimental data reveals influence of study design and publication bias. Stroke 35 (2004) 1203-1208
25. +ATPase activity. Brain Res 571 (1992) 265-271
26. Niitsu Y., Hori O., Yamaguchi A., Bando Y., Ozawa K., Tamatani M., et al. Exposure of cultured primary rat astrocytes to hypoxia results in intracellular glucose depletion and induction of glycolytic enzymes. Brain Res Mol Brain Res 74 (1999) 26-34
27. Paxinos G., and Watson C. The rat brain in stereotaxic coordinates (1986), Academic Press, New York
28. Ramanathan M., Sivakumar S., Anandvijayakumar P.R., Saravana Babu C., and Rathinavel Pandian P. Neuroprotective evaluation of standardized extract of Centella asciatica in monosodium glutamate treated rats. Indian J Exp Biol 45 (2007) 425-431
29. Sadasivam S., and Manickam A. Biochemical methods. 2nd ed. (2003), New age International (P) limited, publisher, Daryaganj (New Delhi)
30. Schulz J.B., Matthews R.T., Henshaw D.R., and Beal M.F. Neuroprotective strategies for treatment of lesions produced by mitochondrial toxins: implications for neurodegenerative diseases. Neurosci 71 (1996) 1043-1048
31. Serteser M., Ozben T., Gumuslu S., Balkan S., and Balkan E. Lipid peroxidation in rat brain during focal cerebral ischemia: prevention of malondialdehyde and lipid conjugated diene production by a novel antiepileptic, lamotrigine. Neurotoxicol 23 (2002) 111-119
32. +ATPase protection against lipoperoxidative damage. Biochem Pharmacol 30 (1981) 427-432
33. Swanson C.J., Bures M., Johnson M.P., Linden A.M., Monn J.A., and Schoepp D.D. Metabotropic glutamate receptors as novel targets for anxiety and stress disorders. Nat Rev Drug Discov 4 (2005) 131-144
34. Thiyagarajan M., and Sharma S.S. Neuroprotective effect of curcumin in middle cerebral artery occlusion induced focal cerebral ischemia in rats. Life Sci 74 (2004) 969-985
35. Yanagisawa D., Kitamura Y., Inden M., Takata K., Taniguchi T., Morikawa S., et al. DJ-1 protects against neurodegeneration caused by focal cerebral ischemia and reperfusion in rats. J Cereb Blood Flow Metab 28 (2008) 563-578
36. Yanpallewar S.U., Sunita R., Mohan K., and Acharya S.B. Evaluation of antioxidant and neuroprotective effect of Ocimum sanctum on transient cerebral ischemia and long-term cerebral hypoperfusion. Pharmacol Biochem Behav 79 (2004) 155-164
37. Zhan C., and Yang J. Protective effects of isoliquiritigenin in transient middle cerebral artery occlusion-induced focal cerebral ischemia in rats. Pharmacol Res 53 (2006) 303-309